4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-028884
Options or other derivatives
- EVP, Chief Commercial Officer acquired 281,221 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Garner Thomas EVP, Chief Commercial Officer | 2024-12-09 | Grant or award · Stock Option (Right to Buy) | +235,849 | 235,849 | D | ||
| Garner Thomas EVP, Chief Commercial Officer | 2024-12-09 | Grant or award · Restricted Stock Units | +45,372 | 45,372 | D | ||
Loading xslF345X05/form4-12102024_111227.xml…